A peptide strategy for inhibiting different protein aggregation pathways in disease
T. Garfagnini, L. Ferrari, M. Koopman, S. Halters, E. Van Kappel, G. Mayer, M. Maurice, S. Rudiger, A. Friedler
The paper develops a peptide strategy that inhibits both amorphous and amyloid protein aggregation by targeting early aggregation stages, showing effectiveness against unrelated proteins like Axin and Tau.
bioRxiv · Oct 22, 2022 · PreprintBiochemistry